Fig. 2From: Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer – focus on overall survivalBiochemical recurrence free survival for low and intermediate risk patients (significantly higher rates for LDR vs. EBRT, p = 0.03, and HDR-BT vs. EBRT, p = 0.03)Back to article page